Browsing targeted aesthetic topics
A new 60-week clinical trial found that semaglutide continued reducing calorie intake by 24% to 30% after one year, helping explain why long-term weight loss remains effective even when early appetite suppression becomes less noticeable.
Rapid vs. gradual weight loss remains one of the most debated topics in weight management. Recent randomized clinical trials suggest that long-term weight loss success depends less on how quickly you lose weight and more on maintenance support, adequate protein, resistance training, and sustainable lifestyle habits.
Medicare’s new GLP-1 Bridge program launched on July 1, 2026, giving eligible Medicare Part D beneficiaries access to select weight-loss medications for a flat $50 monthly copay. Learn who qualifies, which drugs are covered, and how to enroll.
